arrow_back Back to App

Limiting CDC Funds for Infectious Diseases in 2024

This bill proposes to limit the financial resources for the Centers for Disease Control and Prevention (CDC) in the area of emerging and zoonotic infectious diseases for fiscal year 2024. This means the CDC would have less money available for research, prevention, and response to new and existing disease threats, potentially impacting the nation's ability to quickly respond to epidemics and pandemics.
Key points
The bill sets a maximum spending limit for the CDC's emerging and zoonotic infectious diseases programs at $568,372,000 for fiscal year 2024.
Reduced funding could affect the CDC's capacity to monitor, detect, and control disease spread, potentially increasing public health risks.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_1963
Sponsor: Rep. Biggs, Andy [R-AZ-5]
Process start date: 2023-03-29
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Emerging and Zoonotic Infectious Diseases for fiscal year 2024.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_1963.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-03-29.

What are the main provisions?

Key points include:

  • The bill sets a maximum spending limit for the CDC's emerging and zoonotic infectious diseases programs at $568,372,000 for fiscal year 2024.
  • Reduced funding could affect the CDC's capacity to monitor, detect, and control disease spread, potentially increasing public health risks.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Biggs, Andy [R-AZ-5].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health